HK1144373A1 - Use of fungal immunomodulatory protein - Google Patents

Use of fungal immunomodulatory protein

Info

Publication number
HK1144373A1
HK1144373A1 HK10105511.7A HK10105511A HK1144373A1 HK 1144373 A1 HK1144373 A1 HK 1144373A1 HK 10105511 A HK10105511 A HK 10105511A HK 1144373 A1 HK1144373 A1 HK 1144373A1
Authority
HK
Hong Kong
Prior art keywords
immunomodulatory protein
fungal immunomodulatory
fungal
protein
immunomodulatory
Prior art date
Application number
HK10105511.7A
Other languages
English (en)
Inventor
Tzu-Chih Chen
Jiunn-Liang Ko
Original Assignee
Yeastern Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeastern Biotech Co Ltd filed Critical Yeastern Biotech Co Ltd
Publication of HK1144373A1 publication Critical patent/HK1144373A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/375—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Basidiomycetes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/91245—Nucleotidyltransferases (2.7.7)
    • G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
HK10105511.7A 2005-09-23 2010-06-03 Use of fungal immunomodulatory protein HK1144373A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/233,364 US20070071766A1 (en) 2005-09-23 2005-09-23 Compositions comprising fungal immunomodulatory protein and use thereof

Publications (1)

Publication Number Publication Date
HK1144373A1 true HK1144373A1 (en) 2011-02-18

Family

ID=37894299

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10105511.7A HK1144373A1 (en) 2005-09-23 2010-06-03 Use of fungal immunomodulatory protein

Country Status (5)

Country Link
US (1) US20070071766A1 (xx)
EP (2) EP2759304B1 (xx)
JP (2) JP5117696B2 (xx)
CN (3) CN101628110B (xx)
HK (1) HK1144373A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101475632B (zh) * 2008-01-03 2012-01-04 张喜田 具有抗肿瘤作用的重组灵芝免疫调节蛋白及其药物制剂
TWI565474B (zh) * 2008-05-16 2017-01-11 益生生技開發股份有限公司 一種用於增進一抗原之免疫原性的組合物
US8628785B2 (en) 2008-05-16 2014-01-14 Yeastern Biotech Co., Ltd Method for augmenting the immunogenicity of an antigen
TWI606835B (zh) * 2010-04-23 2017-12-01 中央研究院 基於靈芝多醣之組合物及治療癌症之方法
CN102199201B (zh) * 2011-03-22 2013-05-01 上海交通大学 灵芝属内重组的真菌免疫调节蛋白基因、该基因编码的蛋白及其应用
CN102199202B (zh) * 2011-03-22 2013-05-01 上海交通大学 灵芝属间的重组真菌免疫调节蛋白基因、该基因编码的蛋白及其应用
CN102241751B (zh) * 2011-04-20 2013-06-26 中国农业科学院饲料研究所 一种具有抗肿瘤活性的新型真菌免疫调节蛋白fip-nha及其基因
CN103243116B (zh) * 2013-05-08 2015-05-27 上海交通大学 一种属内重组真菌免疫调节蛋白的制备方法及其应用
CN104212828A (zh) * 2013-06-03 2014-12-17 怀化学院 一种重组茯苓免疫调节蛋白wcfip1及其抗体的生产方法
CN103417953B (zh) * 2013-08-16 2015-06-17 张喜田 重组灵芝免疫调节蛋白(rLZ-8)在制备治疗黑色素瘤药物中的应用
CN103739684B (zh) * 2014-01-09 2016-10-05 上海交通大学 黑灵芝真菌免疫调节蛋白的制备方法及其应用
TWI608846B (zh) * 2014-03-13 2017-12-21 益生生技開發股份有限公司 用於改善化學治療所造成之不良副作用的組合療法
CN104001154B (zh) * 2014-06-10 2015-07-01 张喜田 重组灵芝免疫调节蛋白在制备治疗雄激素性脱发药物中的应用
TWI657821B (zh) * 2014-09-02 2019-05-01 益生生技開發股份有限公司 用於治療ｃ－ｍｅｔ相關性癌症的方法和組成物
CN107287166B (zh) * 2016-04-13 2021-04-09 蘑法生物科技股份有限公司 抗蕈类免疫调节蛋白的单株抗体及其应用
TWI702292B (zh) * 2018-12-28 2020-08-21 薩摩亞商康多富國際有限公司 個人化新陳代謝疾病保健食品組合的決定方法及非暫態電腦可讀取儲存媒體
US11141458B2 (en) * 2019-07-17 2021-10-12 Mycomagic Biotechnology Co., Ltd. Composition and methods for promoting and treating chronic wound healing
CN110563822B (zh) * 2019-08-27 2021-09-24 上海交通大学 灵芝免疫调节蛋白突变体及应用
CN113893337A (zh) * 2021-08-31 2022-01-07 中山大学 Dtx2蛋白在制备调控端粒酶活性的制剂中的应用
CN113768812A (zh) * 2021-09-08 2021-12-10 上海交通大学 重组真菌免疫调节蛋白rFIP-glu的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000270713A (ja) * 1999-03-23 2000-10-03 Kennetto:Kk 糖尿病態モデル動物及びその製造方法並びに糖尿病態モデル動物の選定方法
GB0308988D0 (en) * 2003-04-17 2003-05-28 Univ Singapore Molecule
EP1639090A4 (en) * 2003-06-09 2008-04-16 Univ Michigan COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
TWI351963B (en) * 2003-09-17 2011-11-11 Yeastern Biotech Co Ltd Fungal immunomodulatory protein (fip) prepared by
JP2005224205A (ja) * 2004-02-16 2005-08-25 Hokko Chem Ind Co Ltd 健康食品

Also Published As

Publication number Publication date
EP1800690A3 (en) 2007-07-04
JP2007084547A (ja) 2007-04-05
CN101628110B (zh) 2012-09-12
JP2012250991A (ja) 2012-12-20
EP2759304B1 (en) 2016-09-21
CN101926979A (zh) 2010-12-29
EP2759304A1 (en) 2014-07-30
CN1939532B (zh) 2012-10-31
US20070071766A1 (en) 2007-03-29
JP5117696B2 (ja) 2013-01-16
EP1800690A2 (en) 2007-06-27
JP5512769B2 (ja) 2014-06-04
CN101628110A (zh) 2010-01-20
CN1939532A (zh) 2007-04-04
CN101926979B (zh) 2012-09-26

Similar Documents

Publication Publication Date Title
HK1144373A1 (en) Use of fungal immunomodulatory protein
GB0505975D0 (en) Novel use of peptide
GB0514482D0 (en) Protein
GB0417887D0 (en) Protein
GB0511861D0 (en) Proteins
GB0401882D0 (en) Protein
GB0416035D0 (en) Protein
GB0514718D0 (en) Protein
GB0515438D0 (en) Protein
GB0513561D0 (en) Protein
GB0513690D0 (en) Protein
GB0514717D0 (en) Protein
GB0508160D0 (en) Protein
GB0514789D0 (en) Protein
GB0515180D0 (en) Protein
GB0515436D0 (en) Protein
GB0512426D0 (en) Protein
GB0515443D0 (en) Protein
GB0516302D0 (en) Protein
GB0504075D0 (en) Plac-1-like protein
GB0514481D0 (en) Proteins
GB0514788D0 (en) Proteins
GB0513505D0 (en) Proteins
GB0513653D0 (en) Protein stability
GB0400087D0 (en) Protein

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210918